Kampanjeplan Akoya Biosciences, Inc.
Avansert tidsplan
Enkel graf
Om selskapet Akoya Biosciences, Inc.
Akoya Biosciences, Inc., компания, занимающаяся медико-биологическими технологиями, предлагает решения в области пространственной биологии, направленные на трансформацию открытий и клинических исследований в Северной Америке, Азиатско-Тихоокеанском регионе, Европе, на Ближнем Востоке и в Африке. flere detaljer| IPO date | 2021-04-16 |
|---|---|
| ISIN | US00974H1041 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.akoyabio.com |
| Цена ао | 3.03 |
| Prisendring per dag: | 0% (3.07) |
|---|---|
| Prisendring per uke: | +8.87% (2.82) |
| Prisendring per måned: | +24.8% (2.46) |
| Prisendring over 3 måneder: | +5.86% (2.9) |
| Prisendring over seks måneder: | +24.29% (2.47) |
| Prisendring per år: | -39.8% (5.1) |
| Prisendring over 3 år: | -72.12% (11.01) |
| Prisendring over 5 år: | 0% (3.07) |
| Prisendring over 10 år: | 0% (3.07) |
| Prisendring siden begynnelsen av året: | +20.39% (2.55) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Transaksjonsdato | Avsløringsdato | Insider | Type | Pris | Volum | Mengde | Del opp til, % | Del etterpå, % | Dokument |
|---|---|---|---|---|---|---|---|---|---|
| 11.06.2024 | 12.06.2024 | McKelligon Brian President and CEO |
Salg | 2.08 | 15 600 | 7500 | 0 | -0.02 | link |
| 11.06.2024 | 12.06.2024 | McKelligon Brian President and CEO |
Kjøpe | 0.3 | 2 250 | 7500 | 0 | 0.02 | link |
| 07.09.2023 | 11.09.2023 | Pla Frederic Chief Operating Officer |
Kjøpe | 4.6 | 92 000 | 20000 | 0 | 0.05 | link |
| 22.12.2022 | 27.12.2022 | DRISCOLL JOSEPH Chief Financial Officer |
Kjøpe | 0.44 | 110 000 | 250000 | 0 | 0.67 | link |
| 02.12.2022 | 06.12.2022 | Nolan Garry Ph.D. Director |
Salg | 13.25 | 14 575 | 1100 | 0 | 0 | link |
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Blue Water Life Science Advisors, Lp | 4697785 | 9.56 |
| Polar Capital Holdings PLC | 1579756 | 3.21 |
| Vanguard Group Inc | 1408157 | 2.87 |
| Blackrock Inc. | 1372232 | 2.79 |
| Parkman Healthcare Partners LLC | 674787 | 1.37 |
| Uniplan Investment Counsel, Inc. | 673523 | 1.37 |
| Board Of Trustees Of The Leland Stanford Junior University | 620433 | 1.26 |
| SVB Wealth LLC | 515317 | 1.05 |
| Geode Capital Management, LLC | 498175 | 1.01 |
| State Street Corporation | 357591 | 0.73 |
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.01936 | 17.09 | 1.54048 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
iShares Russell 2000 Growth ETF
|
0.00509 | 38.04 | 0.6026 |
Schwab U.S. Small-Cap ETF
|
0.00167 | 17.47 | 1.51433 |
ProShares UltraPro Russell2000
|
0.00165 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00046 | 5.92 | 1.47892 |
Schwab U.S. Broad Market ETF
|
0.00012 | 24.86 | 1.43354 |
| Vanguard Russell 2000 ETF | 0 | 17.16 | 1.48801 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Brian McKelligon | President, CEO & Director | 1.15M | 1969 (56 år) |
| Dr. Frederic G. Pla Ph.D. | Chief Operating Officer | 445.27k | 1959 (66 år) |
| Priyam Shah | Senior Director of Business Development & Investor Relations Strategy | N/A | |
| Mr. John Frederick Ek | CFO, Principal Financial Officer & Principal Accounting Officer | N/A | 1976 (49 år) |
| Ms. Jennifer Kamocsay | General Counsel | N/A | 1971 (54 år) |
| Dr. Niro Ramachandran Ph.D. | Chief Business Officer | 298.18k | 1975 (50 år) |
| Dr. Pascal Bamford Ph.D. | Senior Vice President, Research & Development and Laboratory Operations | N/A | |
| Mr. Rob C. Hart CFA, J.D. | Secretary | N/A |
Adresse: United States, Marlborough. MA, 100 Campus Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.akoyabio.com
Nettsted: https://www.akoyabio.com
